Related Experiment Video
Updated: Jan 16, 2026
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
ABCA4-mutant human retinal organoids sequencing reveals organoids application in inherited retinal diseases
Yourong Bao1, Sujung Soh2, Jean Li3
1HGSC, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA; Department of Biosciences, Rice University, Houston, TX, 77005, USA.
Abstract:
In the studies of Inherited Retinal Diseases (IRDs), the knockout of traditional animal models like mice often fails to accurately replicate human phenotypes due to genetic and anatomical differences. Human retinal organoids (ROs) derived from stem cells have emerged as promising developmental models in retinal studies to delineate cell growth, but their ability to represent the characteristics of late-onset IRDs remains unclear. This study aims to validate ROs as a disease model for Stargardt's Disease (STGD) caused by ABCA4 mutations. Using single-cell RNA sequencing, ROs from 2 STGD patients were compared with healthy control-derived ROs at two developmental stages on both the cellular and transcriptomic levels. The results from gene-level comparisons show promising evidence that ROs successfully capture the underlying molecular variations between patient and control samples even at the early developmental stage, providing the potential of applying ROs to facilitate the study of IRDs and late-onset neurodegenerative diseases.
Insights
Human retinal organoids (ROs) show promise for studying inherited retinal diseases (IRDs). These stem cell-derived models accurately reflect molecular differences in Stargardt
Area of Science:
- Ophthalmology
- Genetics
- Stem Cell Biology
Background:
- Traditional animal models for Inherited Retinal Diseases (IRDs) often fail to replicate human phenotypes due to genetic and anatomical disparities.
- Human retinal organoids (ROs) offer a potential in vitro model for studying retinal development and diseases, but their utility for late-onset IRDs is not well-established.
Purpose of the Study:
- To validate human retinal organoids (ROs) as a disease model for Stargardt's Disease (STGD), a condition caused by ABCA4 mutations.
- To assess the capability of ROs to capture cellular and transcriptomic characteristics of STGD at different developmental stages.
Main Methods:
- Generation of human retinal organoids (ROs) from stem cells derived from two STGD patients and healthy controls.
- Application of single-cell RNA sequencing (scRNA-seq) to compare ROs from STGD patients and controls at two distinct developmental stages.
- Analysis of cellular and transcriptomic profiles to identify disease-specific molecular variations.
Main Results:
- Retinal organoids derived from STGD patients exhibited distinct molecular profiles compared to control organoids.
- Gene-level comparisons revealed that ROs successfully captured underlying molecular variations between patient and control samples, even at early developmental stages.
- scRNA-seq data demonstrated the potential of ROs to model disease-specific transcriptomic changes in STGD.
Conclusions:
- Human retinal organoids (ROs) serve as a viable disease model for Stargardt's Disease (STGD) and potentially other Inherited Retinal Diseases (IRDs).
- ROs can recapitulate key molecular features of STGD, offering a valuable platform for studying the disease.
- This study supports the application of ROs for advancing research into IRDs and late-onset neurodegenerative diseases.
